查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813377

2032 年生物医学纺织品市场预测：按纤维类型、织物类型、应用、最终用户和地区进行的全球分析

Biomedical Textiles Market Forecasts to 2032 - Global Analysis By Fiber Type, Fabric Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球生物医学纺织品市场预计在 2025 年达到 138 亿美元，到 2032 年将达到 196 亿美元，预测期内的复合年增长率为 5.2%。

生物医用纺织品是专为医疗和生物应用而设计的人造纤维材料。这些纺织品用于植入式器械、创伤护理手术和卫生产品，这些领域对生物相容性、耐用性和无菌性至关重要。这些纺织品包括机织、针织、编织和不织布结构，旨在与人体组织和体液安全接触。其应用范围广泛，从缝合线、血管移植物到防护衣和组织支架，其性能取决于机械性能、生物降解性和法规遵循。

老年人口和慢性病日益增多

老龄化社会通常需要植入式和非植入式医用纺织品来用于创伤护理、手术支持和復健。这种人口结构的变化加速了对具有生物相容性、耐用性和抗感染性的先进纺织品解决方案的需求。此外，文明病的增加也促使医疗保健提供者采用纺织品整合设备进行长期病患管理。这些趋势正在推动纺织工程的创新，并扩大生物医学纺织品在临床领域的应用范围。

电子纺织品整合的复杂性

儘管技术不断进步，将电子产品与生物医学纺织品整合仍然是一项重大挑战。感测器、导电纱线和柔性基材的整合需要精密的工程设计，才能在不影响病患安全或舒适度的情况下保持功能性。由于嵌入式电子产品必须符合严格的医疗标准，法规遵循性又增加了复杂性。这些因素导致研发成本高昂，并限制了扩充性，尤其对于希望进入市场的新兴企业和中型企业。

再生医学、组织工程和微创产品开发

生物可吸收纤维和电纺奈米材料的创新正在推动支持细胞生长和组织再生的植入的开发。这些纤维也被整合到微创手术器械中，从而提高手术精度并缩短恢復时间。纤维科学与生物技术的融合正在为个人化医疗开闢新的途径，尤其是在整形外科、心血管修復和创伤治疗。与学术机构和政府支持的研究倡议的合作正在进一步加速该领域的产品开发，为投资和创新创造了肥沃的土壤。

可能的替代产品

市场面临来自替代技术的竞争压力，例如生物工程植入、合成移植物和智慧聚合物，这些技术能够提供类似甚至更好的治疗效果。这些替代方案有望减少对传统纤维解决方案的依赖，尤其是在血管移植物和神经介面等高性能应用中。此外，3D列印和组织工程的进步使得客製化植入的生产成为可能，从而避免了对编织或针织结构的需求。

COVID-19的影响：

新冠疫情对生物医学纺织品产业产生了双重影响。一方面，供应链中断和生产延误尤其阻碍了可植入产品的生产和分销。另一方面，这场危机也加速了对用于急性护理和居家医疗保健的抗菌纺织品、个人防护装备以及创伤护理纺织品的需求。向分散式医疗保健和远端监控的转变也增加了人们对整合感测器的可穿戴生物医学纺织品的兴趣。

预测期内，不可生物降解纤维市场预计将占最大份额

不可生物降解纤维因其卓越的机械强度、耐化学性和长期稳定性，预计将在预测期内占据最大的市场份额。这些纤维，例如聚酯、聚丙烯和聚四氟乙烯，广泛用于缝线、血管移植物和整形外科植入，而这些应用对耐用性至关重要。它们与灭菌过程相容，即使在生理压力下也能保持结构完整性，使其成为永久性或半永久性医疗应用的理想选择，确保其在临床应用中的持续相关性。

心血管植入领域预计将在预测期内以最高复合年增长率成长

心血管植入领域预计将在预测期内实现最高成长率，这得益于心臟病盛行率的上升以及基于纺织品的支架、补片和移植物日益普及。该领域的生物医用纺织品旨在模拟天然组织的弹性和孔隙度，促进内皮化并降低血栓形成的风险。随着微创心血管手术的日益普及，在优惠的报销政策和不断扩展的外科基础设施的支持下，对灵活、生物相容性的纺织植入的需求正在飙升。

占比最大的地区：

在预测期内，北美预计将占据最大的市场份额，这得益于其先进的医疗基础设施、强大的医疗设备製造商以及创新外科解决方案的高采用率。该地区受益于充足的研发资金、简化的监管途径以及日益增长的需要慢性病护理干预的老年人口。学术机构和产业参与者之间的策略伙伴关係正在促进纤维基植入和敷料的快速商业化。

复合年增长率最高的地区：

预计亚太地区在预测期内将实现最高的复合年增长率，这得益于医疗保健覆盖面的扩大、慢性病负担的增加以及政府推动医疗创新的倡议。在有利的贸易政策和不断增长的出口需求的支持下，该地区的纺织业也正利用其生产能力进军生物医药领域。当地新兴企业和研究机构正在探索符合当地需求的经济高效的解决方案，例如可生物降解的伤口敷料和内建感测器的康復服。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生物医学纺织品市场（依纤维类型）

  • 不可生物降解的纤维
    • 聚丙烯（PP）
    • 聚乙烯（PE）
    • 聚酯纤维（PET）
    • 聚酰胺
    • 聚四氟乙烯
  • 可生物降解纤维
    • 棉布
    • 黏胶人造丝
    • 胶原蛋白
    • 几丁质

6. 全球生物医学纺织品市场（依布料类型）

  • 编织
  • 不织布
  • 针织及针织布料
  • 中空布料
  • 其他布料类型

7. 全球生物医学纺织品市场（按应用）

  • 手术缝合线和结扎线
  • 软组织植入
  • 心血管植入
  • 组织工程支架
  • 创伤护理敷料
  • 绷带和OK绷
  • 压力服和手术用织物
  • 体外装置
  • 卫生棉和婴儿尿布
  • 其他用途

8. 全球生物医学纺织品市场（依最终用户）

  • 门诊中心
  • 医院和诊所
  • 社区医疗保健
  • 整形外科诊所
  • 其他最终用户

9. 全球生物医学纺织品市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Atex Technologies, Inc.
  • B. Braun Melsungen AG
  • Bally Ribbon Mills
  • Cardinal Health, Inc.
  • Confluent Medical Technologies
  • DSM（dsm-firmenich）
  • Freudenberg Group
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • Medline Industries, Inc.
  • Medtronic PLC
  • Meister & Cie AG
  • Poly-Med Incorporated
  • Secant Group, LLC
  • Smith & Nephew PLC
  • Swicofil AG
  • Getinge AB
  • Paul Hartmann AG
  • Asahi Kasei Corporation
  • Cortland Biomedical
Product Code: SMRC30824

According to Stratistics MRC, the Global Biomedical Textiles Market is accounted for $13.8 billion in 2025 and is expected to reach $19.6 billion by 2032 growing at a CAGR of 5.2% during the forecast period. Biomedical textiles are engineered fibrous materials specifically designed for medical and biological applications. These textiles are used in implantable devices, wound care, surgical procedures, and hygiene products, where biocompatibility, durability, and sterilizability are critical. They include woven, knitted, braided, and nonwoven structures tailored to interact safely with human tissues and fluids. Applications range from sutures and vascular grafts to protective clothing and tissue scaffolds, with performance governed by mechanical properties, biodegradability, and regulatory compliance

Market Dynamics:

Driver:

Growing geriatric population & rising incidence of chronic diseases

Aging individuals often require implantable and non-implantable medical textiles for wound care, surgical support, and rehabilitation. This demographic shift is accelerating demand for advanced textile-based solutions that offer biocompatibility, durability, and infection resistance. Moreover, the rise in lifestyle-related diseases is prompting healthcare providers to adopt textile-integrated devices for long-term patient management. These trends are fostering innovation in fiber engineering and expanding the scope of biomedical textile applications across clinical settings.

Restraint:

Complexity of electronic-textile integration

Despite technological advancements, integrating electronics with biomedical textiles remains a significant challenge. The fusion of sensors, conductive threads, and flexible substrates requires precise engineering to maintain functionality without compromising patient safety or comfort. Regulatory compliance adds another layer of complexity, as embedded electronics must meet stringent medical standards. These factors contribute to high R&D costs and limit scalability, particularly for startups and mid-sized firms aiming to enter the market.

Opportunity:

Regenerative medicine, tissue engineering & development of minimally invasive products

Innovations in bioresorbable fibers and electrospun nanomaterials are enabling the development of implants that support cell growth and tissue regeneration. These textiles are also being integrated into minimally invasive surgical tools, enhancing precision and reducing recovery times. The convergence of textile science with biotechnology is opening new avenues for personalized medicine, especially in orthopedics, cardiovascular repair, and wound healing. Academic collaborations and government-backed research initiatives are further accelerating product development in this space, making it a fertile ground for investment and innovation.

Threat:

Potential for substitute products

The market faces competitive pressure from alternative technologies such as bioengineered implants, synthetic grafts, and smart polymers that offer similar or superior therapeutic outcomes. These substitutes may reduce reliance on traditional textile-based solutions, especially in high-performance applications like vascular grafts or neural interfaces. Additionally, advancements in 3D printing and tissue engineering are enabling the fabrication of customized implants that bypass the need for woven or knitted structures.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the biomedical textiles sector. On one hand, supply chain disruptions and manufacturing delays hindered production and distribution, especially for implantable products. On the other hand, the crisis accelerated demand for antimicrobial fabrics, PPE, and wound care textiles used in emergency and home-care settings. The shift toward decentralized healthcare and remote monitoring also boosted interest in wearable biomedical textiles embedded with sensors.

The non-biodegradable fibers segment is expected to be the largest during the forecast period

The non-biodegradable fibers segment is expected to account for the largest market share during the forecast period due to their superior mechanical strength, chemical resistance, and long-term stability. These fibers such as polyester, polypropylene, and PTFE are widely used in sutures, vascular grafts, and orthopedic implants where durability is critical. Their compatibility with sterilization processes and ability to maintain structural integrity under physiological stress make them ideal for permanent or semi-permanent medical applications ensuring their continued relevance in clinical use.

The cardiovascular implants segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cardiovascular implants segment is predicted to witness the highest growth rate driven by the rising prevalence of heart diseases and the growing adoption of textile-based stents, patches, and grafts. Biomedical textiles in this domain are engineered to mimic the elasticity and porosity of native tissues, promoting endothelialization and reducing thrombogenic risks. As minimally invasive cardiac procedures become more common, demand for flexible, biocompatible textile implants is surging, supported by favorable reimbursement policies and expanding surgical infrastructure.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its advanced healthcare infrastructure, strong presence of medical device manufacturers, and high adoption of innovative surgical solutions. The region benefits from robust R&D funding, streamlined regulatory pathways, and a growing elderly population requiring chronic care interventions. Strategic partnerships between academic institutions and industry players are fostering rapid commercialization of textile-based implants and dressings.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by expanding healthcare access, rising chronic disease burden, and government initiatives promoting medical innovation. The region's textile industry is also leveraging its production capabilities to enter the biomedical space, supported by favorable trade policies and growing export demand. Local startups and research institutions are exploring cost-effective solutions tailored to regional needs, including biodegradable wound dressings and sensor-embedded rehabilitation garments.

Key players in the market

Some of the key players in Biomedical Textiles Market include Atex Technologies, Inc., B. Braun Melsungen AG, Bally Ribbon Mills, Cardinal Health, Inc., Confluent Medical Technologies, DSM (dsm-firmenich), Freudenberg Group, Integra LifeSciences Corporation, Johnson & Johnson, Medline Industries, Inc., Medtronic PLC, Meister & Cie AG, Poly-Med Incorporated, Secant Group, LLC, Smith & Nephew PLC, Swicofil AG, Getinge AB, Paul Hartmann AG, Asahi Kasei Corporation, and Cortland Biomedical.

Key Developments:

In August 2025, Meister launched its OceanYarn(R) line using recycled ocean-bound plastic, now featured in Schaffner AG's iconic Spaghetti Chair. This partnership highlights sustainable design in Swiss textile innovation. The yarns offer durability and eco-certification for high-end applications.

In July 2025, Getinge expanded its portfolio with the launch of Vasoview Hemopro 3 and a partnership with Zimmer Biomet targeting the ASC segment. The company also reported 4.1% organic sales growth and improved EBITA margins. Paragonix integration exceeded expectations, boosting profitability.

In April 2025, Poly-Med expanded its global footprint with new manufacturing sites and strategic acquisitions to meet rising demand in critical care and cardiology. The company reported 16.6% YoY revenue growth and launched 15+ new products. Its innovation push positions it as a key player in India's medtech sector.

Fiber Types Covered:

  • Non-Biodegradable Fibers
  • Biodegradable Fibers

Fabric Types Covered:

  • Woven
  • Non-Woven
  • Knitted & Braided Fabrics
  • Hollow Fabrics
  • Other Fabric Types

Applications Covered:

  • Surgical Sutures & Ligatures
  • Soft Tissue Implants
  • Cardiovascular Implants
  • Tissue Engineering Scaffolds
  • Wound Care Dressings
  • Bandages & Plasters
  • Compression Garments & Surgical Textiles
  • Extracorporeal Devices
  • Sanitary Napkins & Baby Diapers
  • Other Applications

Technologies Covered:

  • Online Monitoring Systems
  • Offline Monitoring Systems
  • Remote Monitoring Systems

End Users Covered:

  • Ambulatory Centers
  • Hospitals & Clinics
  • Community Healthcare
  • Orthopedic Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biomedical Textiles Market, By Fiber Type

  • 5.1 Introduction
  • 5.2 Non-Biodegradable Fibers
    • 5.2.1 Polypropylene (PP)
    • 5.2.2 Polyethylene (PE)
    • 5.2.3 Polyester (PET)
    • 5.2.4 Polyamide
    • 5.2.5 Polytetrafluoroethylene
  • 5.3 Biodegradable Fibers
    • 5.3.1 Cotton
    • 5.3.2 Viscose Rayon
    • 5.3.3 Collagen
    • 5.3.4 Chitin

6 Global Biomedical Textiles Market, By Fabric Type

  • 6.1 Introduction
  • 6.2 Woven
  • 6.3 Non-Woven
  • 6.4 Knitted & Braided Fabrics
  • 6.5 Hollow Fabrics
  • 6.6 Other Fabric Types

7 Global Biomedical Textiles Market, By Application

  • 7.1 Introduction
  • 7.2 Surgical Sutures & Ligatures
  • 7.3 Soft Tissue Implants
  • 7.4 Cardiovascular Implants
  • 7.5 Tissue Engineering Scaffolds
  • 7.6 Wound Care Dressings
  • 7.7 Bandages & Plasters
  • 7.8 Compression Garments & Surgical Textiles
  • 7.9 Extracorporeal Devices
  • 7.10 Sanitary Napkins & Baby Diapers
  • 7.11 Other Applications

8 Global Biomedical Textiles Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Centers
  • 8.3 Hospitals & Clinics
  • 8.4 Community Healthcare
  • 8.5 Orthopedic Clinics
  • 8.6 Other End Users

9 Global Biomedical Textiles Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Atex Technologies, Inc.
  • 11.2 B. Braun Melsungen AG
  • 11.3 Bally Ribbon Mills
  • 11.4 Cardinal Health, Inc.
  • 11.5 Confluent Medical Technologies
  • 11.6 DSM (dsm-firmenich)
  • 11.7 Freudenberg Group
  • 11.8 Integra LifeSciences Corporation
  • 11.9 Johnson & Johnson
  • 11.10 Medline Industries, Inc.
  • 11.11 Medtronic PLC
  • 11.12 Meister & Cie AG
  • 11.13 Poly-Med Incorporated
  • 11.14 Secant Group, LLC
  • 11.15 Smith & Nephew PLC
  • 11.16 Swicofil AG
  • 11.17 Getinge AB
  • 11.18 Paul Hartmann AG
  • 11.19 Asahi Kasei Corporation
  • 11.20 Cortland Biomedical

List of Tables

  • Table 1 Global Biomedical Textiles Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Biomedical Textiles Market Outlook, By Fiber Type (2024-2032) ($MN)
  • Table 3 Global Biomedical Textiles Market Outlook, By Non-Biodegradable Fibers (2024-2032) ($MN)
  • Table 4 Global Biomedical Textiles Market Outlook, By Polypropylene (PP) (2024-2032) ($MN)
  • Table 5 Global Biomedical Textiles Market Outlook, By Polyethylene (PE) (2024-2032) ($MN)
  • Table 6 Global Biomedical Textiles Market Outlook, By Polyester (PET) (2024-2032) ($MN)
  • Table 7 Global Biomedical Textiles Market Outlook, By Polyamide (2024-2032) ($MN)
  • Table 8 Global Biomedical Textiles Market Outlook, By Polytetrafluoroethylene (2024-2032) ($MN)
  • Table 9 Global Biomedical Textiles Market Outlook, By Biodegradable Fibers (2024-2032) ($MN)
  • Table 10 Global Biomedical Textiles Market Outlook, By Cotton (2024-2032) ($MN)
  • Table 11 Global Biomedical Textiles Market Outlook, By Viscose Rayon (2024-2032) ($MN)
  • Table 12 Global Biomedical Textiles Market Outlook, By Collagen (2024-2032) ($MN)
  • Table 13 Global Biomedical Textiles Market Outlook, By Chitin (2024-2032) ($MN)
  • Table 14 Global Biomedical Textiles Market Outlook, By Fabric Type (2024-2032) ($MN)
  • Table 15 Global Biomedical Textiles Market Outlook, By Woven (2024-2032) ($MN)
  • Table 16 Global Biomedical Textiles Market Outlook, By Non-Woven (2024-2032) ($MN)
  • Table 17 Global Biomedical Textiles Market Outlook, By Knitted & Braided Fabrics (2024-2032) ($MN)
  • Table 18 Global Biomedical Textiles Market Outlook, By Hollow Fabrics (2024-2032) ($MN)
  • Table 19 Global Biomedical Textiles Market Outlook, By Other Fabric Types (2024-2032) ($MN)
  • Table 20 Global Biomedical Textiles Market Outlook, By Application (2024-2032) ($MN)
  • Table 21 Global Biomedical Textiles Market Outlook, By Surgical Sutures & Ligatures (2024-2032) ($MN)
  • Table 22 Global Biomedical Textiles Market Outlook, By Soft Tissue Implants (2024-2032) ($MN)
  • Table 23 Global Biomedical Textiles Market Outlook, By Cardiovascular Implants (2024-2032) ($MN)
  • Table 24 Global Biomedical Textiles Market Outlook, By Tissue Engineering Scaffolds (2024-2032) ($MN)
  • Table 25 Global Biomedical Textiles Market Outlook, By Wound Care Dressings (2024-2032) ($MN)
  • Table 26 Global Biomedical Textiles Market Outlook, By Bandages & Plasters (2024-2032) ($MN)
  • Table 27 Global Biomedical Textiles Market Outlook, By Compression Garments & Surgical Textiles (2024-2032) ($MN)
  • Table 28 Global Biomedical Textiles Market Outlook, By Extracorporeal Devices (2024-2032) ($MN)
  • Table 29 Global Biomedical Textiles Market Outlook, By Sanitary Napkins & Baby Diapers (2024-2032) ($MN)
  • Table 30 Global Biomedical Textiles Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 31 Global Biomedical Textiles Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 Global Biomedical Textiles Market Outlook, By Ambulatory Centers (2024-2032) ($MN)
  • Table 33 Global Biomedical Textiles Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 34 Global Biomedical Textiles Market Outlook, By Community Healthcare (2024-2032) ($MN)
  • Table 35 Global Biomedical Textiles Market Outlook, By Orthopedic Clinics (2024-2032) ($MN)
  • Table 36 Global Biomedical Textiles Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.